1Hansen L, Deacon C F, Otsk. C, et al. Glucagon-like peptide-1(7-36)amide is transformed to glucagons-like peptide-1-(9-36)amide by dipetidyl peptidase Ⅳ in the capillaries supplying the L cells of the porcine intestine. Endocrinology,1999,140:5356-5363.
2Eizirik D L, Darville M I. Beta cell apoptosis and defense mechanisms: lessons from type 1 diabetes. Diabetes, 2001,50(suppl 1):S64-S69.
3Kurrer M O, Pakala S V, Hanson HL, et al. β cell apoptosis in T cell mediated autoimmune diabetes. Proc Natl Acad Sci USA,1997,94:213-218.
4Lally FJ, Ratcliff H, Bone AJ. Apoptosis and disease progression in the spontaneously diabetic BB/S rat. Diabetologia,2001,44:320-324.
5Kagi D, Ho A, Odermat B, et al. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes. J Immunol,1999,162:4598-4605.
6Shimabukuro M, Zhou YT, Levi M, et al. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A,1998, 95:2498-2502.
7Federici M, Hribal M, Perego L, et al. High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific bcl family genes toward an apoptotic cell death program. Diabetes,2001, 50:1290-1301.
8Ritzel, R A, Butler P C. Replication increases b-cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Diabetes,2003, 52:1701-1708.
9Butler A E, Janson J, Bonner-Weir S, et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes,2003, 52:102-110.
10Drucker D J. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care,2003, 26:2929-2940.
